Cilostazol
Generic name: Pronounced as (sil oh' sta zol)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 09/15/2015
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What should I do if I forget a dose?
- What side effects can this medication cause?
- What should I know about STORAGE and DISPOSAL of this medication?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Drug interactions
IMPORTANT WARNING
Medications similar to cilostazol caused an increased risk of death in patients with congestive heart failure (condition in which the heart is unable to pump enough blood to the other parts of the body). Tell your doctor if you have or have ever had congestive heart failure. Your doctor will probably tell you not to take cilostazol.
Talk to your doctor about the risks of taking cilostazol.
Why is this medication prescribed?
Cilostazol is used to reduce the symptoms of intermittent claudication (pain in the legs that worsens when walking and improves when resting that is caused by narrowing of the blood vessels that supply blood to the legs). Cilostazol is in a class of medications called platelet-aggregation inhibitors (antiplatelet medications). It works by improving blood flow to the legs.
How should this medicine be used?
Cilostazol comes as a tablet to take by mouth. It is usually taken twice a day, at least 30 minutes before or 2 hours after breakfast and dinner. Take cilostazol at around the same times every day. Follow the directions on the prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take cilostazol exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Cilostazol controls the symptoms of intermittent claudication but does not cure it. Although you may notice improvements in 2 to 4 weeks, it may take up to 12 weeks before you notice the full benefit (increased walking distance) of cilostazol. Continue taking cilostazol even if you feel well. Do not stop taking cilostazol without talking to your doctor.
Other uses for this medicine
This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking cilostazol,
-
tell your doctor and pharmacist if you are allergic to cilostazol, any other medications, or any of the ingredients in cilostazol. Ask your pharmacist for a list of the ingredients.
-
tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: anticoagulants (''blood thinners'') such as warfarin (Coumadin); aspirin; antifungal medications such as fluconazole (Diflucan), itraconazole (Sporanox), and ketoconazole (Nizoral); antiplatelet medications such as clopidogrel (Plavix), prasugrel (Effient), and ticlopidine (Ticlid); clarithromycin (Biaxin); diltiazem (Cardizem, Dilacor, Tiazac, others); erythromycin (E-mycin, Ery-Tab, others); fluoxetine (Prozac); fluvoxamine (Luvox); nefazadone; omeprazole (Prilosec); and sertraline (Zoloft). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
-
tell your doctor if you have bleeding ulcers (sores in the lining of the stomach or small intestine that are bleeding), bleeding in the brain, bleeding from any other part of your body, a low number of platelets in your blood, or any other condition that causes severe bleeding. Your doctor will probably tell you not to take cilostazol.
-
tell your doctor if you have or have ever had heart, kidney, or liver disease.
-
tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking cilostazol, call your doctor.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
-
Cilostazol may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
-
headache
-
diarrhea
-
dizziness
-
heartburn
-
nausea
-
stomach pain
-
muscle pain
-
-
Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately:
-
fast or irregular heartbeat
-
unusual bleeding or bruising
-
swelling of the arms, hands, feet, ankles, or lower legs
-
-
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
What should I know about STORAGE and DISPOSAL of this medication?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
Symptoms of overdose may include the following:
-
severe headache
-
dizziness
-
fainting
-
diarrhea
-
fast or irregular heartbeat
What OTHER INFORMATION should I know?
Keep all appointments with your doctor.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Moxifloxacin | Moxifloxacin The metabolism of Cilostazol can be decreased when combined with Moxifloxacin. |
Insulin Glargine (rDNA origin) Injection | Insulin Glargine (rDNA origin) Injection The metabolism of Cilostazol can be increased when combined with Insulin glargine. |
Leflunomide | Leflunomide The serum concentration of Cilostazol can be decreased when it is combined with Leflunomide. |
Delavirdine | Delavirdine The serum concentration of Cilostazol can be increased when it is combined with Delavirdine. |
Nevirapine | Nevirapine The metabolism of Cilostazol can be decreased when combined with Nevirapine. |
Atorvastatin | Atorvastatin The metabolism of Cilostazol can be decreased when combined with Atorvastatin. |
Dolasetron | Dolasetron The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Dolasetron. |
Aminophylline | Aminophylline The metabolism of Aminophylline can be decreased when combined with Cilostazol. |
Anagrelide | Anagrelide The risk or severity of congestive heart failure, bleeding, hypotension, and Tachycardia can be increased when Anagrelide is combined with Cilostazol. |
Clopidogrel | Clopidogrel Clopidogrel may increase the antiplatelet activities of Cilostazol. |
Erythromycin and Sulfisoxazole | Erythromycin and Sulfisoxazole The metabolism of Cilostazol can be decreased when combined with Erythromycin. |
Estrogen and Progestin (Oral Contraceptives) | Estrogen and Progestin (Oral Contraceptives) The metabolism of Cilostazol can be decreased when combined with Conjugated estrogens. |
Fenofibrate | Fenofibrate The serum concentration of Cilostazol can be increased when it is combined with Fenofibrate. |
Guanfacine | Guanfacine Guanfacine may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Magnesium Hydroxide | Magnesium Hydroxide Cilostazol may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level. |
Methylergonovine | Methylergonovine The metabolism of Cilostazol can be decreased when combined with Methylergometrine. |
Mycophenolate | Mycophenolate Mycophenolic acid may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Olsalazine | Olsalazine The risk or severity of bleeding can be increased when Olsalazine is combined with Cilostazol. |
Penbutolol | Penbutolol The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Acebutolol. |
Potassium | Potassium Potassium may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy. |
Prednisone | Prednisone Prednisone may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Ranitidine | Ranitidine The metabolism of Cilostazol can be decreased when combined with Ranitidine. |
Reserpine | Reserpine The metabolism of Cilostazol can be increased when combined with Reserpine. |
Rizatriptan | Rizatriptan Rizatriptan may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Sumatriptan | Sumatriptan Sumatriptan may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Tacrolimus | Tacrolimus The metabolism of Cilostazol can be decreased when combined with Tacrolimus. |
Tizanidine | Tizanidine The metabolism of Cilostazol can be decreased when combined with Tizanidine. |
Triamcinolone | Triamcinolone The metabolism of Cilostazol can be increased when combined with Triamcinolone. |
Zolmitriptan | Zolmitriptan The metabolism of Cilostazol can be decreased when combined with Zolmitriptan. |
Ampicillin Injection | Ampicillin Injection Ampicillin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Doxycycline Injection | Doxycycline Injection Doxycycline may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Famotidine Injection | Famotidine Injection The risk or severity of QTc prolongation can be increased when Famotidine is combined with Cilostazol. |
Fluconazole Injection | Fluconazole Injection The serum concentration of Cilostazol can be increased when it is combined with Fluconazole. |
Foscarnet Injection | Foscarnet Injection Foscarnet may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Hydromorphone Injection | Hydromorphone Injection Hydromorphone may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Interferon Beta-1b Injection | Interferon Beta-1b Injection The metabolism of Cilostazol can be decreased when combined with Interferon beta-1b. |
Interferon Gamma-1b Injection | Interferon Gamma-1b Injection The metabolism of Cilostazol can be decreased when combined with Interferon gamma-1b. |
Levofloxacin Injection | Levofloxacin Injection The metabolism of Cilostazol can be decreased when combined with Levofloxacin. |
Meperidine Injection | Meperidine Injection The metabolism of Cilostazol can be increased when combined with Meperidine. |
Metoclopramide Injection | Metoclopramide Injection The metabolism of Cilostazol can be decreased when combined with Metoclopramide. |
Metronidazole Injection | Metronidazole Injection The metabolism of Cilostazol can be decreased when combined with Metronidazole. |
Pamidronate Injection | Pamidronate Injection Pamidronic acid may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Vancomycin Injection | Vancomycin Injection Cilostazol may decrease the excretion rate of Vancomycin which could result in a higher serum level. |
Zidovudine Injection | Zidovudine Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Zidovudine. |
Altretamine | Altretamine The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Cilostazol. |
Cefuroxime | Cefuroxime Cefuroxime may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Cyclosporine | Cyclosporine The metabolism of Cilostazol can be decreased when combined with Cyclosporine. |
Ondansetron | Ondansetron The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Ondansetron. |
Enoxaparin Injection | Enoxaparin Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Enoxaparin. |
Granisetron | Granisetron The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Granisetron. |
Torsemide | Torsemide Torasemide may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy. |
Olanzapine | Olanzapine The serum concentration of Cilostazol can be increased when it is combined with Olanzapine. |
Alosetron | Alosetron The metabolism of Cilostazol can be decreased when combined with Alosetron. |
Dofetilide | Dofetilide The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Dofetilide. |
Entacapone | Entacapone The metabolism of Cilostazol can be decreased when combined with Entacapone. |
Hydroxychloroquine | Hydroxychloroquine The metabolism of Cilostazol can be decreased when combined with Hydroxychloroquine. |
Meloxicam | Meloxicam The risk or severity of bleeding can be increased when Meloxicam is combined with Cilostazol. |
Oxcarbazepine | Oxcarbazepine The serum concentration of Cilostazol can be increased when it is combined with Oxcarbazepine. |
Pantoprazole | Pantoprazole The serum concentration of Cilostazol can be increased when it is combined with Pantoprazole. |
Telmisartan | Telmisartan The serum concentration of Cilostazol can be increased when it is combined with Telmisartan. |
Temozolomide | Temozolomide Temozolomide may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Zaleplon | Zaleplon Zaleplon may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Anakinra | Anakinra The metabolism of Cilostazol can be increased when combined with Anakinra. |
Desloratadine | Desloratadine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Desloratadine. |
Linezolid | Linezolid The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Cilostazol. |
Pentosan Polysulfate | Pentosan Polysulfate The risk or severity of adverse effects can be increased when Pentosan polysulfate is combined with Cilostazol. |
Trimipramine | Trimipramine The metabolism of Cilostazol can be decreased when combined with Trimipramine. |
Etanercept Injection | Etanercept Injection The metabolism of Cilostazol can be increased when combined with Etanercept. |
Glycopyrrolate | Glycopyrrolate The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Cilostazol. |
Modafinil | Modafinil The serum concentration of Cilostazol can be increased when it is combined with Modafinil. |
Perindopril | Perindopril Perindopril may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Tenofovir | Tenofovir Tenofovir may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Choline Magnesium Trisalicylate | Choline Magnesium Trisalicylate The risk or severity of bleeding can be increased when Choline magnesium trisalicylate is combined with Cilostazol. |
Sirolimus | Sirolimus The metabolism of Sirolimus can be decreased when combined with Cilostazol. |
Dutasteride | Dutasteride The metabolism of Cilostazol can be decreased when combined with Dutasteride. |
Epinephrine Injection | Epinephrine Injection The metabolism of Cilostazol can be decreased when combined with Epinephrine. |
Epirubicin | Epirubicin The risk or severity of bleeding can be increased when Epirubicin is combined with Cilostazol. |
Eplerenone | Eplerenone Eplerenone may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy. |
Escitalopram | Escitalopram The serum concentration of Cilostazol can be increased when it is combined with Escitalopram. |
Zonisamide | Zonisamide The serum concentration of Cilostazol can be increased when it is combined with Zonisamide. |
Adalimumab Injection | Adalimumab Injection The metabolism of Cilostazol can be increased when combined with Adalimumab. |
Aripiprazole | Aripiprazole The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Aripiprazole. |
Atomoxetine | Atomoxetine The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Cilostazol. |
Atazanavir | Atazanavir The metabolism of Cilostazol can be decreased when combined with Atazanavir. |
Almotriptan | Almotriptan Almotriptan may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Eletriptan | Eletriptan The metabolism of Cilostazol can be decreased when combined with Eletriptan. |
Mefloquine | Mefloquine The metabolism of Cilostazol can be decreased when combined with Mefloquine. |
Rosuvastatin | Rosuvastatin The metabolism of Cilostazol can be decreased when combined with Rosuvastatin. |
Vardenafil | Vardenafil The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Cilostazol. |
Alfuzosin | Alfuzosin The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Cilostazol. |
Aprepitant | Aprepitant The serum concentration of Cilostazol can be increased when it is combined with Aprepitant. |
Emtricitabine | Emtricitabine Emtricitabine may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Interferon Beta-1a Subcutaneous Injection | Interferon Beta-1a Subcutaneous Injection The metabolism of Cilostazol can be decreased when combined with Interferon beta-1a. |
Memantine | Memantine The serum concentration of Cilostazol can be increased when it is combined with Memantine. |
Tegaserod | Tegaserod The metabolism of Cilostazol can be decreased when combined with Tegaserod. |
Tadalafil | Tadalafil Tadalafil may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Frovatriptan | Frovatriptan The metabolism of Cilostazol can be decreased when combined with Frovatriptan. |
Gemifloxacin | Gemifloxacin The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Gemifloxacin. |
Progesterone | Progesterone The serum concentration of Cilostazol can be increased when it is combined with Progesterone. |
Apomorphine Injection | Apomorphine Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Cilostazol. |
Infliximab Injection | Infliximab Injection The metabolism of Cilostazol can be increased when combined with Infliximab. |
Protriptyline | Protriptyline The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Cilostazol. |
Duloxetine | Duloxetine The metabolism of Cilostazol can be decreased when combined with Duloxetine. |
Norethindrone | Norethindrone The metabolism of Cilostazol can be decreased when combined with Norethisterone. |
Tinidazole | Tinidazole Tinidazole may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Trospium | Trospium The metabolism of Cilostazol can be decreased when combined with Trospium. |
Cefditoren | Cefditoren Cefdinir may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Cinacalcet | Cinacalcet The metabolism of Cilostazol can be decreased when combined with Cinacalcet. |
Cyanocobalamin Injection | Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Erlotinib | Erlotinib The metabolism of Cilostazol can be decreased when combined with Erlotinib. |
Eszopiclone | Eszopiclone Eszopiclone may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Ganciclovir | Ganciclovir Ganciclovir may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Ribavirin | Ribavirin Ribavirin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Solifenacin | Solifenacin The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Solifenacin. |
Valganciclovir | Valganciclovir Cilostazol may decrease the excretion rate of Valganciclovir which could result in a higher serum level. |
Voriconazole | Voriconazole The serum concentration of Cilostazol can be increased when it is combined with Voriconazole. |
Adefovir | Adefovir Adefovir may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Dextroamphetamine | Dextroamphetamine The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Cilostazol. |
Entecavir | Entecavir The metabolism of Cilostazol can be decreased when combined with Entecavir. |
Peginterferon Alfa-2a Injection | Peginterferon Alfa-2a Injection The metabolism of Cilostazol can be decreased when combined with Peginterferon alfa-2a. |
Peginterferon Alfa-2b (PEG-Intron) | Peginterferon Alfa-2b (PEG-Intron) The serum concentration of Cilostazol can be increased when it is combined with Peginterferon alfa-2b. |
Ibandronate | Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Cilostazol. |
Isocarboxazid | Isocarboxazid The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Cilostazol. |
Ramelteon | Ramelteon The metabolism of Cilostazol can be decreased when combined with Ramelteon. |
Darifenacin | Darifenacin The metabolism of Darifenacin can be decreased when combined with Cilostazol. |
Fentanyl | Fentanyl The metabolism of Cilostazol can be decreased when combined with Fentanyl. |
Pregabalin | Pregabalin The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Cilostazol. |
Deferasirox | Deferasirox The serum concentration of Cilostazol can be increased when it is combined with Deferasirox. |
Phenylephrine | Phenylephrine The metabolism of Cilostazol can be increased when combined with Phenylephrine. |
Tipranavir | Tipranavir Tipranavir may increase the antiplatelet activities of Cilostazol. |
Felbamate | Felbamate The serum concentration of Cilostazol can be increased when it is combined with Felbamate. |
Ranolazine | Ranolazine The metabolism of Ranolazine can be decreased when combined with Cilostazol. |
Abatacept Injection | Abatacept Injection The metabolism of Cilostazol can be increased when combined with Abatacept. |
Rasagiline | Rasagiline The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Cilostazol. |
Imatinib | Imatinib The metabolism of Cilostazol can be decreased when combined with Imatinib. |
Sitagliptin | Sitagliptin Cilostazol may decrease the excretion rate of Sitagliptin which could result in a higher serum level. |
Varenicline | Varenicline Cilostazol may decrease the excretion rate of Varenicline which could result in a higher serum level. |
Gefitinib | Gefitinib The serum concentration of Cilostazol can be increased when it is combined with Gefitinib. |
Albuterol | Albuterol The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Cilostazol. |
Paliperidone | Paliperidone The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Paliperidone. |
Bortezomib | Bortezomib The serum concentration of Cilostazol can be increased when it is combined with Bortezomib. |
Clofarabine Injection | Clofarabine Injection Clofarabine may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Insulin Glulisine (rDNA origin) Injection | Insulin Glulisine (rDNA origin) Injection The metabolism of Cilostazol can be increased when combined with Insulin glulisine. |
Lubiprostone | Lubiprostone Lubiprostone may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Oxaliplatin Injection | Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Oxaliplatin. |
Posaconazole | Posaconazole The metabolism of Cilostazol can be decreased when combined with Posaconazole. |
Primaquine | Primaquine The metabolism of Cilostazol can be decreased when combined with Primaquine. |
Rituximab Injection | Rituximab Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Rituximab. |
Bismuth Subsalicylate | Bismuth Subsalicylate The risk or severity of bleeding can be increased when Cilostazol is combined with Bismuth subsalicylate. |
Darunavir | Darunavir The metabolism of Cilostazol can be decreased when combined with Darunavir. |
Pemetrexed Injection | Pemetrexed Injection Cilostazol may decrease the excretion rate of Pemetrexed which could result in a higher serum level. |
Dimenhydrinate | Dimenhydrinate The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Dimenhydrinate. |
Lisdexamfetamine | Lisdexamfetamine The risk or severity of Tachycardia can be increased when Cilostazol is combined with Lisdexamfetamine. |
Nabilone | Nabilone The risk or severity of Tachycardia can be increased when Nabilone is combined with Cilostazol. |
Vorinostat | Vorinostat The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Vorinostat. |
Sorafenib | Sorafenib The serum concentration of Cilostazol can be increased when it is combined with Sorafenib. |
Sunitinib | Sunitinib The metabolism of Cilostazol can be decreased when combined with Sunitinib. |
Dronabinol | Dronabinol The risk or severity of Tachycardia can be increased when Dronabinol is combined with Cilostazol. |
Lapatinib | Lapatinib The metabolism of Cilostazol can be decreased when combined with Lapatinib. |
Levocetirizine | Levocetirizine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Levocetirizine. |
Pegaptanib Injection | Pegaptanib Injection Cilostazol may decrease the excretion rate of Pegaptanib which could result in a higher serum level. |
Dasatinib | Dasatinib Dasatinib may increase the anticoagulant activities of Cilostazol. |
Mexiletine | Mexiletine The metabolism of Cilostazol can be decreased when combined with Mexiletine. |
Omega-3 Fatty Acids | Omega-3 Fatty Acids Omega-3 fatty acids may increase the antiplatelet activities of Cilostazol. |
Armodafinil | Armodafinil The serum concentration of Cilostazol can be increased when it is combined with Armodafinil. |
Azacitidine Injection | Azacitidine Injection Azacitidine may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Temsirolimus | Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Cilostazol. |
Nelarabine Injection | Nelarabine Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Nelarabine. |
Lenalidomide | Lenalidomide Lenalidomide may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Nilotinib | Nilotinib The metabolism of Cilostazol can be decreased when combined with Nilotinib. |
Toremifene | Toremifene The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Toremifene. |
Bexarotene | Bexarotene The risk or severity of bleeding can be increased when Cilostazol is combined with Bexarotene. |
Budesonide | Budesonide The metabolism of Cilostazol can be increased when combined with Budesonide. |
Chloramphenicol Injection | Chloramphenicol Injection The serum concentration of Cilostazol can be increased when it is combined with Chloramphenicol. |
Decitabine Injection | Decitabine Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Decitabine. |
Desmopressin | Desmopressin Desmopressin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Doripenem Injection | Doripenem Injection Cilostazol may decrease the excretion rate of Doripenem which could result in a higher serum level. |
Etravirine | Etravirine The serum concentration of Cilostazol can be increased when it is combined with Etravirine. |
Arsenic Trioxide Injection | Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Arsenic trioxide. |
Mitoxantrone Injection | Mitoxantrone Injection The metabolism of Cilostazol can be decreased when combined with Mitoxantrone. |
Desvenlafaxine | Desvenlafaxine The metabolism of Cilostazol can be decreased when combined with Desvenlafaxine. |
Cevimeline | Cevimeline Cevimeline may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Nebivolol | Nebivolol The metabolism of Nebivolol can be decreased when combined with Cilostazol. |
Tretinoin | Tretinoin The metabolism of Cilostazol can be decreased when combined with Tretinoin. |
Bendamustine Injection | Bendamustine Injection The metabolism of Bendamustine can be decreased when combined with Cilostazol. |
Pilocarpine | Pilocarpine The metabolism of Cilostazol can be decreased when combined with Pilocarpine. |
Flecainide | Flecainide The metabolism of Flecainide can be decreased when combined with Cilostazol. |
Certolizumab Injection | Certolizumab Injection The metabolism of Cilostazol can be increased when combined with Certolizumab pegol. |
Ixabepilone Injection | Ixabepilone Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Ixabepilone. |
Irinotecan Injection | Irinotecan Injection The metabolism of Cilostazol can be decreased when combined with Irinotecan. |
Daptomycin Injection | Daptomycin Injection Daptomycin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Praziquantel | Praziquantel The metabolism of Cilostazol can be decreased when combined with Praziquantel. |
Methylnaltrexone Injection | Methylnaltrexone Injection Cilostazol may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level. |
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) | Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of bleeding can be increased when Cilostazol is combined with Alemtuzumab. |
Midazolam | Midazolam The metabolism of Cilostazol can be decreased when combined with Midazolam. |
Dexrazoxane Injection | Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Eltrombopag | Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Cilostazol. |
Ibritumomab Injection | Ibritumomab Injection The risk or severity of adverse effects can be increased when Cilostazol is combined with Ibritumomab tiuxetan. |
Milnacipran | Milnacipran The metabolism of Cilostazol can be decreased when combined with Milnacipran. |
Plerixafor Injection | Plerixafor Injection Cilostazol may decrease the excretion rate of Plerixafor which could result in a higher serum level. |
Fesoterodine | Fesoterodine Cilostazol may decrease the excretion rate of Fesoterodine which could result in a higher serum level. |
Degarelix Injection | Degarelix Injection The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Degarelix. |
Betaxolol | Betaxolol The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Betaxolol. |
Iloperidone | Iloperidone The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Iloperidone. |
Prasugrel | Prasugrel The risk or severity of bleeding can be increased when Cilostazol is combined with Prasugrel. |
Everolimus | Everolimus The metabolism of Everolimus can be decreased when combined with Cilostazol. |
Tolvaptan (low blood sodium) | Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy. |
Dronedarone | Dronedarone The metabolism of Cilostazol can be decreased when combined with Dronedarone. |
Pralatrexate Injection | Pralatrexate Injection Cilostazol may decrease the excretion rate of Pralatrexate which could result in a higher serum level. |
Palonosetron Injection | Palonosetron Injection Palonosetron may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Saxagliptin | Saxagliptin Cilostazol may decrease the excretion rate of Saxagliptin which could result in a higher serum level. |
Telavancin Injection | Telavancin Injection The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Telavancin. |
Romidepsin Injection | Romidepsin Injection The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Romidepsin. |
Tapentadol | Tapentadol The metabolism of Cilostazol can be decreased when combined with Tapentadol. |
Topotecan | Topotecan The metabolism of Cilostazol can be decreased when combined with Topotecan. |
Golimumab Injection | Golimumab Injection The metabolism of Cilostazol can be increased when combined with Golimumab. |
Pazopanib | Pazopanib The metabolism of Cilostazol can be decreased when combined with Pazopanib. |
Asenapine | Asenapine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Asenapine. |
Albendazole | Albendazole The metabolism of Cilostazol can be decreased when combined with Albendazole. |
Levonorgestrel | Levonorgestrel The metabolism of Cilostazol can be decreased when combined with Levonorgestrel. |
Oxymorphone | Oxymorphone The metabolism of Oxymorphone can be decreased when combined with Cilostazol. |
Dabigatran | Dabigatran The risk or severity of bleeding can be increased when Cilostazol is combined with Dabigatran. |
Tocilizumab Injection | Tocilizumab Injection The metabolism of Cilostazol can be increased when combined with Tocilizumab. |
Dalfampridine | Dalfampridine Cilostazol may decrease the excretion rate of Dalfampridine which could result in a higher serum level. |
Eribulin Injection | Eribulin Injection The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Eribulin. |
Cabazitaxel Injection | Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Cilostazol. |
Ceftaroline Injection | Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Lurasidone | Lurasidone The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Lurasidone. |
Acetaminophen Injection | Acetaminophen Injection The metabolism of Cilostazol can be decreased when combined with Acetaminophen. |
Vilazodone | Vilazodone The metabolism of Cilostazol can be decreased when combined with Vilazodone. |
Ipilimumab Injection | Ipilimumab Injection Cilostazol may decrease the excretion rate of Ipilimumab which could result in a higher serum level. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection The metabolism of Cilostazol can be decreased when combined with Aldesleukin. |
Terbutaline Injection | Terbutaline Injection The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Cilostazol. |
Busulfan Injection | Busulfan Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Busulfan. |
Roflumilast | Roflumilast Cilostazol may decrease the excretion rate of Roflumilast which could result in a higher serum level. |
Linagliptin | Linagliptin The metabolism of Cilostazol can be decreased when combined with Linagliptin. |
Rilpivirine | Rilpivirine The metabolism of Cilostazol can be decreased when combined with Rilpivirine. |
Cyclophosphamide Injection | Cyclophosphamide Injection The metabolism of Cilostazol can be decreased when combined with Cyclophosphamide. |
Abiraterone | Abiraterone The serum concentration of Cilostazol can be increased when it is combined with Abiraterone. |
Triptorelin Injection | Triptorelin Injection The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Triptorelin. |
Rivaroxaban | Rivaroxaban Cilostazol may increase the anticoagulant activities of Rivaroxaban. |
Ticagrelor | Ticagrelor The metabolism of Cilostazol can be decreased when combined with Ticagrelor. |
Brentuximab Vedotin Injection | Brentuximab Vedotin Injection The metabolism of Cilostazol can be decreased when combined with Brentuximab vedotin. |
Ruxolitinib | Ruxolitinib Cilostazol may decrease the excretion rate of Ruxolitinib which could result in a higher serum level. |
Vandetanib | Vandetanib The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Vandetanib. |
Clobazam | Clobazam The metabolism of Cilostazol can be decreased when combined with Clobazam. |
Vemurafenib | Vemurafenib The serum concentration of Cilostazol can be increased when it is combined with Vemurafenib. |
Vismodegib | Vismodegib The serum concentration of Cilostazol can be increased when it is combined with Vismodegib. |
Ivacaftor | Ivacaftor The metabolism of Cilostazol can be decreased when combined with Ivacaftor. |
Deferiprone | Deferiprone Cilostazol may decrease the excretion rate of Deferiprone which could result in a higher serum level. |
Axitinib | Axitinib The metabolism of Axitinib can be decreased when combined with Cilostazol. |
Crizotinib | Crizotinib The metabolism of Cilostazol can be decreased when combined with Crizotinib. |
Melphalan Injection | Melphalan Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Melphalan. |
Cabergoline | Cabergoline The metabolism of Cilostazol can be decreased when combined with Cabergoline. |
Naloxone Injection | Naloxone Injection The metabolism of Cilostazol can be decreased when combined with Naloxone. |
Ambrisentan | Ambrisentan The metabolism of Ambrisentan can be decreased when combined with Cilostazol. |
Fondaparinux Injection | Fondaparinux Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Fondaparinux. |
Carfilzomib Injection | Carfilzomib Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Carfilzomib. |
Iloprost | Iloprost The risk or severity of bleeding can be increased when Cilostazol is combined with Iloprost. |
Enzalutamide | Enzalutamide Cilostazol may decrease the excretion rate of Enzalutamide which could result in a higher serum level. |
Mirabegron | Mirabegron The metabolism of Mirabegron can be decreased when combined with Cilostazol. |
Regorafenib | Regorafenib The metabolism of Cilostazol can be decreased when combined with Regorafenib. |
Bosutinib | Bosutinib The metabolism of Cilostazol can be decreased when combined with Bosutinib. |
Teriflunomide | Teriflunomide The serum concentration of Cilostazol can be decreased when it is combined with Teriflunomide. |
Teduglutide Injection | Teduglutide Injection Cilostazol may decrease the excretion rate of Teduglutide which could result in a higher serum level. |
Bedaquiline | Bedaquiline The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Bedaquiline. |
Icosapent Ethyl | Icosapent Ethyl Cilostazol may increase the antiplatelet activities of Icosapent ethyl. |
Tofacitinib | Tofacitinib The risk or severity of bleeding can be increased when Cilostazol is combined with Tofacitinib. |
Alogliptin | Alogliptin Cilostazol may decrease the excretion rate of Alogliptin which could result in a higher serum level. |
Ponatinib | Ponatinib The metabolism of Ponatinib can be decreased when combined with Cilostazol. |
Pomalidomide | Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Cilostazol. |
Ado-trastuzumab Emtansine Injection | Ado-trastuzumab Emtansine Injection The metabolism of Cilostazol can be decreased when combined with Trastuzumab emtansine. |
Apixaban | Apixaban The risk or severity of adverse effects can be increased when Cilostazol is combined with Apixaban. |
Canagliflozin | Canagliflozin Cilostazol may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Methazolamide | Methazolamide Methazolamide may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy. |
Dabrafenib | Dabrafenib The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Dabrafenib. |
Ospemifene | Ospemifene The metabolism of Cilostazol can be decreased when combined with Ospemifene. |
Trametinib | Trametinib Cilostazol may decrease the excretion rate of Trametinib which could result in a higher serum level. |
Levomilnacipran | Levomilnacipran Levomilnacipran may increase the antiplatelet activities of Cilostazol. |
Ertapenem Injection | Ertapenem Injection Ertapenem may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Vortioxetine | Vortioxetine Cilostazol may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Perampanel | Perampanel The metabolism of Perampanel can be decreased when combined with Cilostazol. |
Ibrutinib | Ibrutinib The risk or severity of adverse effects can be increased when Ibrutinib is combined with Cilostazol. |
Lomitapide | Lomitapide The metabolism of Cilostazol can be decreased when combined with Lomitapide. |
Ketorolac Injection | Ketorolac Injection The risk or severity of bleeding can be increased when Ketorolac is combined with Cilostazol. |
Obinutuzumab Injection | Obinutuzumab Injection The risk or severity of adverse effects can be increased when Cilostazol is combined with Obinutuzumab. |
Simeprevir | Simeprevir The metabolism of Cilostazol can be decreased when combined with Simeprevir. |
Sofosbuvir | Sofosbuvir Cilostazol may decrease the excretion rate of Sofosbuvir which could result in a higher serum level. |
Dapagliflozin | Dapagliflozin The metabolism of Cilostazol can be decreased when combined with Dapagliflozin. |
Apremilast | Apremilast The metabolism of Cilostazol can be increased when combined with Apremilast. |
Droxidopa | Droxidopa Cilostazol may decrease the excretion rate of Droxidopa which could result in a higher serum level. |
Ceritinib | Ceritinib The metabolism of Cilostazol can be decreased when combined with Ceritinib. |
Siltuximab Injection | Siltuximab Injection The metabolism of Cilostazol can be decreased when combined with Siltuximab. |
Eslicarbazepine | Eslicarbazepine The serum concentration of Cilostazol can be increased when it is combined with Eslicarbazepine. |
Belinostat Injection | Belinostat Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Belinostat. |
Idelalisib | Idelalisib The metabolism of Cilostazol can be decreased when combined with Idelalisib. |
Testosterone Injection | Testosterone Injection Testosterone may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Oritavancin Injection | Oritavancin Injection The serum concentration of Cilostazol can be increased when it is combined with Oritavancin. |
Vorapaxar | Vorapaxar The risk or severity of bleeding can be increased when Cilostazol is combined with Vorapaxar. |
Edoxaban | Edoxaban The risk or severity of bleeding can be increased when Cilostazol is combined with Edoxaban. |
Peginterferon Beta-1a Injection | Peginterferon Beta-1a Injection The metabolism of Cilostazol can be decreased when combined with Peginterferon beta-1a. |
Olaparib | Olaparib The metabolism of Cilostazol can be decreased when combined with Olaparib. |
Blinatumomab Injection | Blinatumomab Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Blinatumomab. |
Methamphetamine | Methamphetamine Cilostazol may decrease the excretion rate of Metamfetamine which could result in a higher serum level. |
Tasimelteon | Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Cilostazol. |
Riociguat | Riociguat Cilostazol may increase the hypotensive activities of Riociguat. |
Lanreotide Injection | Lanreotide Injection The metabolism of Cilostazol can be decreased when combined with Lanreotide. |
Pirfenidone | Pirfenidone The metabolism of Pirfenidone can be decreased when combined with Cilostazol. |
Secukinumab Injection | Secukinumab Injection The metabolism of Cilostazol can be increased when combined with Secukinumab. |
Risperidone Injection | Risperidone Injection The risk or severity of QTc prolongation can be increased when Risperidone is combined with Cilostazol. |
Palbociclib | Palbociclib The metabolism of Cilostazol can be decreased when combined with Palbociclib. |
Insulin Human Inhalation | Insulin Human Inhalation The metabolism of Cilostazol can be increased when combined with Insulin human. |
Lenvatinib | Lenvatinib The serum concentration of Cilostazol can be increased when it is combined with Lenvatinib. |
Naloxegol | Naloxegol The serum concentration of Cilostazol can be increased when it is combined with Naloxegol. |
Panobinostat | Panobinostat The metabolism of Cilostazol can be decreased when combined with Panobinostat. |
Dinutuximab Injection | Dinutuximab Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Dinutuximab. |
Haloperidol Injection | Haloperidol Injection The metabolism of Cilostazol can be decreased when combined with Haloperidol. |
Deoxycholic Acid Injection | Deoxycholic Acid Injection The risk or severity of adverse effects can be increased when Cilostazol is combined with Deoxycholic acid. |
Ivabradine | Ivabradine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Ivabradine. |
Amiloride | Amiloride Amiloride may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy. |
Isavuconazonium Injection | Isavuconazonium Injection The metabolism of Cilostazol can be decreased when combined with Isavuconazonium. |
Macitentan | Macitentan Cilostazol may decrease the excretion rate of Macitentan which could result in a higher serum level. |
Rolapitant | Rolapitant The metabolism of Cilostazol can be decreased when combined with Rolapitant. |
Daclatasvir | Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Cilostazol. |
Brexpiprazole | Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Cilostazol. |
Ziprasidone Injection | Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Cilostazol. |
Cariprazine | Cariprazine The metabolism of Cariprazine can be decreased when combined with Cilostazol. |
Penicillin G Procaine Injection | Penicillin G Procaine Injection Cilostazol may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level. |
Insulin Degludec (rDNA Origin) Injection | Insulin Degludec (rDNA Origin) Injection The metabolism of Cilostazol can be increased when combined with Insulin degludec. |
Trabectedin Injection | Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Cilostazol. |
Osimertinib | Osimertinib The metabolism of Cilostazol can be decreased when combined with Osimertinib. |
Ixazomib | Ixazomib Cilostazol may decrease the excretion rate of Ixazomib which could result in a higher serum level. |
Lesinurad | Lesinurad Cilostazol may decrease the excretion rate of Lesinurad which could result in a higher serum level. |
Amphotericin B Liposomal Injection | Amphotericin B Liposomal Injection The metabolism of Cilostazol can be decreased when combined with Amphotericin B. |
Dexamethasone Injection | Dexamethasone Injection The metabolism of Cilostazol can be decreased when combined with Dexamethasone. |
Defibrotide Injection | Defibrotide Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Defibrotide. |
Brivaracetam Injection | Brivaracetam Injection Cilostazol may decrease the excretion rate of Brivaracetam which could result in a higher serum level. |
Venetoclax | Venetoclax The metabolism of Cilostazol can be decreased when combined with Venetoclax. |
Cobicistat | Cobicistat The metabolism of Cilostazol can be decreased when combined with Cobicistat. |
Midodrine | Midodrine The risk or severity of Tachycardia can be increased when Midodrine is combined with Cilostazol. |
Obeticholic Acid | Obeticholic Acid The risk or severity of adverse effects can be increased when Cilostazol is combined with Obeticholic acid. |
Diphenhydramine Injection | Diphenhydramine Injection The metabolism of Cilostazol can be decreased when combined with Diphenhydramine. |
Furosemide Injection | Furosemide Injection Furosemide may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy. |
Rucaparib | Rucaparib The serum concentration of Cilostazol can be increased when it is combined with Rucaparib. |
Lixisenatide Injection | Lixisenatide Injection Cilostazol may decrease the excretion rate of Lixisenatide which could result in a higher serum level. |
Ribociclib | Ribociclib The metabolism of Cilostazol can be decreased when combined with Ribociclib. |
Doxepin (Insomnia) | Doxepin (Insomnia) The metabolism of Cilostazol can be decreased when combined with Doxepin. |
Deutetrabenazine | Deutetrabenazine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Deutetrabenazine. |
Valbenazine | Valbenazine Cilostazol may decrease the excretion rate of Valbenazine which could result in a higher serum level. |
Deflazacort | Deflazacort The metabolism of Cilostazol can be increased when combined with Deflazacort. |
Safinamide | Safinamide The serum concentration of Cilostazol can be increased when it is combined with Safinamide. |
Naldemedine | Naldemedine Cilostazol may decrease the excretion rate of Naldemedine which could result in a higher serum level. |
Sarilumab Injection | Sarilumab Injection The metabolism of Cilostazol can be decreased when combined with Sarilumab. |
Midostaurin | Midostaurin The serum concentration of Cilostazol can be increased when it is combined with Midostaurin. |
Enasidenib | Enasidenib The serum concentration of Cilostazol can be increased when it is combined with Enasidenib. |
Aprepitant/Fosaprepitant Injection | Aprepitant/Fosaprepitant Injection The metabolism of Cilostazol can be decreased when combined with Fosaprepitant. |
Benznidazole | Benznidazole Cilostazol may decrease the excretion rate of Benznidazole which could result in a higher serum level. |
Copanlisib Injection | Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Cilostazol. |
Delafloxacin | Delafloxacin The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Delafloxacin. |
Betrixaban | Betrixaban The risk or severity of bleeding can be increased when Cilostazol is combined with Betrixaban. |
Acalabrutinib | Acalabrutinib The metabolism of Cilostazol can be decreased when combined with Acalabrutinib. |
Gemtuzumab Ozogamicin Injection | Gemtuzumab Ozogamicin Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Gemtuzumab ozogamicin. |
Letermovir | Letermovir The metabolism of Cilostazol can be decreased when combined with Letermovir. |
Tetrabenazine | Tetrabenazine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Tetrabenazine. |
Ertugliflozin | Ertugliflozin Ertugliflozin may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy. |
Buprenorphine Injection | Buprenorphine Injection The serum concentration of Cilostazol can be increased when it is combined with Buprenorphine. |
Apalutamide | Apalutamide Cilostazol may decrease the excretion rate of Apalutamide which could result in a higher serum level. |
Penicillamine | Penicillamine The risk or severity of bleeding can be increased when Cilostazol is combined with Penicillamine. |
Fostamatinib | Fostamatinib The metabolism of Cilostazol can be decreased when combined with Fostamatinib. |
Baricitinib | Baricitinib Cilostazol may decrease the excretion rate of Baricitinib which could result in a higher serum level. |
Lofexidine | Lofexidine The metabolism of Lofexidine can be decreased when combined with Cilostazol. |
Plazomicin Injection | Plazomicin Injection Cilostazol may decrease the excretion rate of Plazomicin which could result in a higher serum level. |
Eliglustat | Eliglustat The metabolism of Cilostazol can be decreased when combined with Eliglustat. |
Encorafenib | Encorafenib The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Encorafenib. |
Binimetinib | Binimetinib The metabolism of Binimetinib can be decreased when combined with Cilostazol. |
Ivosidenib | Ivosidenib The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Ivosidenib. |
Elagolix | Elagolix The metabolism of Elagolix can be decreased when combined with Cilostazol. |
Doravirine | Doravirine The metabolism of Doravirine can be decreased when combined with Cilostazol. |
Tafenoquine | Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Cilostazol. |
Cannabidiol | Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Cilostazol. |
Dacomitinib | Dacomitinib The metabolism of Cilostazol can be decreased when combined with Dacomitinib. |
Stiripentol | Stiripentol The serum concentration of Cilostazol can be increased when it is combined with Stiripentol. |
Gilteritinib | Gilteritinib The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Gilteritinib. |
Glasdegib | Glasdegib The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Glasdegib. |
Lorlatinib | Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Cilostazol. |
Paclitaxel (with albumin) Injection | Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Cilostazol. |
Rifamycin | Rifamycin The serum concentration of Cilostazol can be increased when it is combined with Rifamycin. |
Prucalopride | Prucalopride Cilostazol may decrease the excretion rate of Prucalopride which could result in a higher serum level. |
Emapalumab-lzsg Injection | Emapalumab-lzsg Injection The metabolism of Cilostazol can be increased when combined with Emapalumab. |
Acyclovir Ophthalmic | Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Caplacizumab-yhdp Injection | Caplacizumab-yhdp Injection Cilostazol may increase the antiplatelet activities of Caplacizumab. |
Esomeprazole Injection | Esomeprazole Injection The serum concentration of Cilostazol can be increased when it is combined with Esomeprazole. |
Alpelisib | Alpelisib The metabolism of Cilostazol can be decreased when combined with Alpelisib. |
Cladribine | Cladribine The risk or severity of bleeding can be increased when Cilostazol is combined with Cladribine. |
Solriamfetol | Solriamfetol The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Cilostazol. |
Triclabendazole | Triclabendazole The serum concentration of Cilostazol can be increased when it is combined with Triclabendazole. |
Entrectinib | Entrectinib The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Entrectinib. |
Istradefylline | Istradefylline The metabolism of Istradefylline can be decreased when combined with Cilostazol. |
Pitolisant | Pitolisant The serum concentration of Cilostazol can be decreased when it is combined with Pitolisant. |
Fedratinib | Fedratinib The metabolism of Cilostazol can be decreased when combined with Fedratinib. |
Lefamulin | Lefamulin Lefamulin may increase the QTc-prolonging activities of Cilostazol. |
Phenytoin Injection | Phenytoin Injection The metabolism of Cilostazol can be increased when combined with Phenytoin. |
Fosphenytoin Injection | Fosphenytoin Injection The metabolism of Cilostazol can be increased when combined with Fosphenytoin. |
Cenobamate | Cenobamate The metabolism of Cilostazol can be decreased when combined with Cenobamate. |
Selumetinib | Selumetinib The metabolism of Selumetinib can be decreased when combined with Cilostazol. |
Tucatinib | Tucatinib The metabolism of Tucatinib can be decreased when combined with Cilostazol. |
Remdesivir Injection | Remdesivir Injection The metabolism of Cilostazol can be decreased when combined with Remdesivir. |
Capmatinib | Capmatinib The metabolism of Cilostazol can be decreased when combined with Capmatinib. |
Lemborexant | Lemborexant The metabolism of Lemborexant can be decreased when combined with Cilostazol. |
Fenfluramine | Fenfluramine The metabolism of Cilostazol can be decreased when combined with Fenfluramine. |
Fostemsavir | Fostemsavir The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Fostemsavir. |
Octreotide | Octreotide The metabolism of Cilostazol can be decreased when combined with Octreotide. |
Pralsetinib | Pralsetinib The metabolism of Cilostazol can be decreased when combined with Pralsetinib. |
Satralizumab-mwge Injection | Satralizumab-mwge Injection The serum concentration of Cilostazol can be decreased when it is combined with Satralizumab. |
Relugolix | Relugolix The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Relugolix. |
Progestin-Only (drospirenone) Oral Contraceptives | Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy. |
Viloxazine | Viloxazine Cilostazol may decrease the excretion rate of Viloxazine which could result in a higher serum level. |
Vitamin E (Alpha-Tocopherol) | Vitamin E (Alpha-Tocopherol) Vitamin E may increase the antiplatelet activities of Cilostazol. |
Tobramycin Injection | Tobramycin Injection Tobramycin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Theophylline | Theophylline The metabolism of Cilostazol can be decreased when combined with Theophylline. |
Fenoprofen | Fenoprofen The risk or severity of bleeding can be increased when Fenoprofen is combined with Cilostazol. |
Indomethacin | Indomethacin The serum concentration of Cilostazol can be increased when it is combined with Indomethacin. |
Mefenamic Acid | Mefenamic Acid The risk or severity of bleeding can be increased when Mefenamic acid is combined with Cilostazol. |
Naproxen | Naproxen The risk or severity of bleeding can be increased when Naproxen is combined with Cilostazol. |
Tolmetin | Tolmetin The risk or severity of bleeding can be increased when Tolmetin is combined with Cilostazol. |
Sulindac | Sulindac The risk or severity of bleeding can be increased when Sulindac is combined with Cilostazol. |
Trazodone | Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Cilostazol. |
Isotretinoin | Isotretinoin Isotretinoin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Sucralfate | Sucralfate Sucralfate may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Hydroxyurea | Hydroxyurea The metabolism of Cilostazol can be decreased when combined with Hydroxyurea. |
Floxuridine | Floxuridine Floxuridine may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Phenobarbital | Phenobarbital The metabolism of Cilostazol can be increased when combined with Phenobarbital. |
Metaxalone | Metaxalone Metaxalone may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Methotrexate Injection | Methotrexate Injection Methotrexate may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Primidone | Primidone The metabolism of Cilostazol can be increased when combined with Primidone. |
Methsuximide | Methsuximide The serum concentration of Cilostazol can be increased when it is combined with Methsuximide. |
Diethylpropion | Diethylpropion The risk or severity of Tachycardia can be increased when Diethylpropion is combined with Cilostazol. |
Chlorpromazine | Chlorpromazine The metabolism of Cilostazol can be decreased when combined with Chlorpromazine. |
Diazepam | Diazepam The serum concentration of Cilostazol can be increased when it is combined with Diazepam. |
Oxazepam | Oxazepam Oxazepam may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Flurazepam | Flurazepam Flurazepam may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Clorazepate | Clorazepate Clorazepic acid may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Lorazepam | Lorazepam Lorazepam may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Carmustine | Carmustine The metabolism of Cilostazol can be decreased when combined with Carmustine. |
Amantadine | Amantadine The risk or severity of QTc prolongation can be increased when Amantadine is combined with Cilostazol. |
Codeine | Codeine Codeine may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Bromocriptine | Bromocriptine The metabolism of Cilostazol can be decreased when combined with Bromocriptine. |
Metaproterenol | Metaproterenol The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Cilostazol. |
Tranylcypromine | Tranylcypromine The serum concentration of Cilostazol can be increased when it is combined with Tranylcypromine. |
Phenelzine | Phenelzine The serum concentration of Cilostazol can be increased when it is combined with Phenelzine. |
Procarbazine | Procarbazine The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Cilostazol. |
Tetracycline | Tetracycline The metabolism of Cilostazol can be decreased when combined with Tetracycline. |
Thioguanine | Thioguanine The risk or severity of bleeding can be increased when Cilostazol is combined with Tioguanine. |
Prochlorperazine | Prochlorperazine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Prochlorperazine. |
Thioridazine | Thioridazine The metabolism of Cilostazol can be decreased when combined with Thioridazine. |
Trifluoperazine | Trifluoperazine The metabolism of Cilostazol can be decreased when combined with Trifluoperazine. |
Bleomycin | Bleomycin Bleomycin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Dapsone | Dapsone The metabolism of Cilostazol can be decreased when combined with Dapsone. |
Sulfadiazine | Sulfadiazine Sulfadiazine may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Oxycodone | Oxycodone The metabolism of Cilostazol can be decreased when combined with Oxycodone. |
Methadone | Methadone The metabolism of Cilostazol can be decreased when combined with Methadone. |
Oxybutynin | Oxybutynin The metabolism of Cilostazol can be decreased when combined with Oxybutynin. |
Benztropine | Benztropine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Cilostazol. |
Maprotiline | Maprotiline The metabolism of Cilostazol can be decreased when combined with Maprotiline. |
Ibuprofen | Ibuprofen The risk or severity of bleeding can be increased when Ibuprofen is combined with Cilostazol. |
Trihexyphenidyl | Trihexyphenidyl The risk or severity of Tachycardia can be increased when Trihexyphenidyl is combined with Cilostazol. |
Orphenadrine | Orphenadrine The metabolism of Cilostazol can be decreased when combined with Orphenadrine. |
Perphenazine | Perphenazine The metabolism of Cilostazol can be decreased when combined with Perphenazine. |
Azathioprine | Azathioprine The metabolism of Cilostazol can be decreased when combined with Azathioprine. |
Fluphenazine | Fluphenazine The metabolism of Cilostazol can be decreased when combined with Fluphenazine. |
Phentermine | Phentermine The risk or severity of Tachycardia can be increased when Phentermine is combined with Cilostazol. |
Methylphenidate | Methylphenidate Methylphenidate may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Amoxapine | Amoxapine The metabolism of Cilostazol can be decreased when combined with Amoxapine. |
Sulfasalazine | Sulfasalazine The risk or severity of bleeding can be increased when Sulfasalazine is combined with Cilostazol. |
Hydrocortisone | Hydrocortisone The metabolism of Cilostazol can be decreased when combined with Hydrocortisone. |
Lomustine | Lomustine The risk or severity of bleeding can be increased when Cilostazol is combined with Lomustine. |
Doxorubicin | Doxorubicin The metabolism of Cilostazol can be decreased when combined with Doxorubicin. |
Cytarabine | Cytarabine The risk or severity of bleeding can be increased when Cilostazol is combined with Cytarabine. |
Mechlorethamine | Mechlorethamine The risk or severity of bleeding can be increased when Cilostazol is combined with Mechlorethamine. |
Dactinomycin | Dactinomycin The risk or severity of bleeding can be increased when Cilostazol is combined with Dactinomycin. |
Phenazopyridine | Phenazopyridine Phenazopyridine may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Carbamazepine | Carbamazepine The serum concentration of Cilostazol can be increased when it is combined with Carbamazepine. |
Methyldopa | Methyldopa Methyldopa may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Clonidine | Clonidine The metabolism of Cilostazol can be decreased when combined with Clonidine. |
Hydralazine | Hydralazine The metabolism of Cilostazol can be decreased when combined with Hydralazine. |
Cimetidine | Cimetidine The serum concentration of Cilostazol can be increased when it is combined with Cimetidine. |
Gentamicin Injection | Gentamicin Injection Gentamicin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Warfarin | Warfarin The serum concentration of Cilostazol can be increased when it is combined with Warfarin. |
Clonazepam | Clonazepam Clonazepam may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Loperamide | Loperamide The metabolism of Cilostazol can be decreased when combined with Loperamide. |
Promethazine | Promethazine The metabolism of Cilostazol can be decreased when combined with Promethazine. |
Meclofenamate | Meclofenamate The risk or severity of bleeding can be increased when Meclofenamic acid is combined with Cilostazol. |
Daunorubicin | Daunorubicin The metabolism of Cilostazol can be decreased when combined with Daunorubicin. |
Nitrofurantoin | Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Griseofulvin | Griseofulvin The metabolism of Cilostazol can be increased when combined with Griseofulvin. |
Digoxin | Digoxin Cilostazol may decrease the excretion rate of Digoxin which could result in a higher serum level. |
Chloroquine | Chloroquine The metabolism of Cilostazol can be decreased when combined with Chloroquine. |
Quinine | Quinine The serum concentration of Cilostazol can be increased when it is combined with Quinine. |
Ethosuximide | Ethosuximide The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Cilostazol. |
Triamterene | Triamterene The metabolism of Cilostazol can be decreased when combined with Triamterene. |
Sulfinpyrazone | Sulfinpyrazone Sulfinpyrazone may increase the antiplatelet activities of Cilostazol. |
Chlorothiazide | Chlorothiazide Chlorothiazide may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy. |
Chlorthalidone | Chlorthalidone Chlorthalidone may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy. |
Metolazone | Metolazone Metolazone may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy. |
Isosorbide | Isosorbide Isosorbide may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy. |
Clindamycin Injection | Clindamycin Injection The metabolism of Clindamycin can be decreased when combined with Cilostazol. |
Secobarbital | Secobarbital The metabolism of Cilostazol can be increased when combined with Secobarbital. |
Desipramine | Desipramine The metabolism of Cilostazol can be decreased when combined with Desipramine. |
Amitriptyline | Amitriptyline The serum concentration of Cilostazol can be increased when it is combined with Amitriptyline. |
Imipramine | Imipramine The serum concentration of Cilostazol can be increased when it is combined with Imipramine. |
Probenecid | Probenecid The serum concentration of Cilostazol can be increased when it is combined with Probenecid. |
Quinidine | Quinidine The metabolism of Cilostazol can be decreased when combined with Quinidine. |
Procainamide | Procainamide The metabolism of Procainamide can be decreased when combined with Cilostazol. |
Isoniazid | Isoniazid The serum concentration of Cilostazol can be increased when it is combined with Isoniazid. |
Pyrazinamide | Pyrazinamide Pyrazinamide may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Rifampin | Rifampin The metabolism of Cilostazol can be increased when combined with Rifampicin. |
Disopyramide | Disopyramide The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Disopyramide. |
Valproic Acid | Valproic Acid The serum concentration of Cilostazol can be increased when it is combined with Valproic acid. |
Tamoxifen | Tamoxifen The metabolism of Cilostazol can be decreased when combined with Tamoxifen. |
Mitomycin | Mitomycin The risk or severity of bleeding can be increased when Cilostazol is combined with Mitomycin. |
Butabarbital | Butabarbital Butabarbital may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Liothyronine | Liothyronine Liothyronine may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Methimazole | Methimazole The serum concentration of Cilostazol can be increased when it is combined with Methimazole. |
Propylthiouracil | Propylthiouracil The risk or severity of bleeding can be increased when Cilostazol is combined with Propylthiouracil. |
Chlorpropamide | Chlorpropamide Chlorpropamide may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Tolbutamide | Tolbutamide Tolbutamide may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Tolazamide | Tolazamide Tolazamide may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Dextromethorphan | Dextromethorphan The metabolism of Cilostazol can be decreased when combined with Dextromethorphan. |
Cyclobenzaprine | Cyclobenzaprine The metabolism of Cilostazol can be decreased when combined with Cyclobenzaprine. |
Niacin | Niacin The metabolism of Cilostazol can be decreased when combined with Niacin. |
Baclofen | Baclofen Baclofen may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Doxylamine | Doxylamine The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Cilostazol. |
Cyproheptadine | Cyproheptadine The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Cilostazol. |
Clemastine | Clemastine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Clemastine. |
Chlorpheniramine | Chlorpheniramine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Chlorpheniramine. |
Brompheniramine | Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Cilostazol. |
Meclizine | Meclizine The metabolism of Cilostazol can be decreased when combined with Meclizine. |
Ethambutol | Ethambutol Ethambutol may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Methyclothiazide | Methyclothiazide Methyclothiazide may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy. |
Hydrochlorothiazide | Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Chlorzoxazone | Chlorzoxazone The metabolism of Cilostazol can be decreased when combined with Chlorzoxazone. |
Pyridoxine | Pyridoxine Pyridoxine may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Folic Acid | Folic Acid Folic acid may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Danazol | Danazol The metabolism of Cilostazol can be decreased when combined with Danazol. |
Disulfiram | Disulfiram The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Cilostazol. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Propranolol. |
Pseudoephedrine | Pseudoephedrine The risk or severity of Tachycardia can be increased when Pseudoephedrine is combined with Cilostazol. |
Nortriptyline | Nortriptyline The metabolism of Cilostazol can be decreased when combined with Nortriptyline. |
Spironolactone | Spironolactone Spironolactone may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy. |
Amphotericin B Injection | Amphotericin B Injection The metabolism of Cilostazol can be decreased when combined with Amphotericin B. |
Mercaptopurine | Mercaptopurine The risk or severity of bleeding can be increased when Cilostazol is combined with Mercaptopurine. |
Phytonadione | Phytonadione Phylloquinone may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Amikacin Injection | Amikacin Injection Amikacin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Nadolol | Nadolol Cilostazol may decrease the excretion rate of Nadolol which could result in a higher serum level. |
Allopurinol | Allopurinol Allopurinol may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Oxytocin Injection | Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Cilostazol. |
Flavoxate | Flavoxate Flavoxate may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Papaverine | Papaverine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Papaverine. |
Fluorouracil Injection | Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Fluorouracil. |
Colchicine | Colchicine The metabolism of Cilostazol can be decreased when combined with Colchicine. |
Cefaclor | Cefaclor Cefaclor may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Cefadroxil | Cefadroxil Cefadroxil may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Cefazolin Injection | Cefazolin Injection Cefazolin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Cephalexin | Cephalexin Cephalexin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Cefoxitin Injection | Cefoxitin Injection Cefoxitin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Dacarbazine | Dacarbazine The metabolism of Cilostazol can be decreased when combined with Dacarbazine. |
Acetazolamide | Acetazolamide The metabolism of Cilostazol can be decreased when combined with Acetazolamide. |
Cefotaxime Injection | Cefotaxime Injection Cefotaxime may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Calcitonin Salmon Injection | Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Ketoconazole | Ketoconazole The serum concentration of Cilostazol can be increased when it is combined with Ketoconazole. |
Pyrantel | Pyrantel Cilostazol may decrease the excretion rate of Pyrantel which could result in a higher serum level. |
Thiotepa Injection | Thiotepa Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Thiotepa. |
Vincristine Injection | Vincristine Injection The metabolism of Cilostazol can be decreased when combined with Vincristine. |
Dipyridamole | Dipyridamole The risk or severity of bleeding can be increased when Cilostazol is combined with Dipyridamole. |
Isoxsuprine | Isoxsuprine The risk or severity of Tachycardia can be increased when Cilostazol is combined with Isoxsuprine. |
Vinblastine | Vinblastine The metabolism of Cilostazol can be decreased when combined with Vinblastine. |
Ethacrynic Acid | Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Colistimethate Injection | Colistimethate Injection Colistimethate may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Metoprolol | Metoprolol The metabolism of Cilostazol can be decreased when combined with Metoprolol. |
Hydroxyzine | Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Cilostazol. |
Thiothixene | Thiothixene The metabolism of Thiothixene can be decreased when combined with Cilostazol. |
Aspirin | Aspirin Acetylsalicylic acid may increase the antiplatelet activities of Cilostazol. |
Salsalate | Salsalate The risk or severity of bleeding can be increased when Salsalate is combined with Cilostazol. |
Chlorambucil | Chlorambucil The risk or severity of bleeding can be increased when Cilostazol is combined with Chlorambucil. |
Alprazolam | Alprazolam Alprazolam may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Temazepam | Temazepam Temazepam may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Triazolam | Triazolam Triazolam may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Dicyclomine | Dicyclomine Dicyclomine may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Hyoscyamine | Hyoscyamine The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Cilostazol. |
Propantheline | Propantheline Propantheline may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Trimethoprim | Trimethoprim Trimethoprim may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Diltiazem | Diltiazem The metabolism of Cilostazol can be decreased when combined with Diltiazem. |
Nifedipine | Nifedipine The metabolism of Cilostazol can be decreased when combined with Nifedipine. |
Timolol | Timolol The risk or severity of QTc prolongation can be increased when Timolol is combined with Cilostazol. |
Verapamil | Verapamil The metabolism of Cilostazol can be decreased when combined with Verapamil. |
Atenolol | Atenolol The metabolism of Cilostazol can be decreased when combined with Atenolol. |
Pindolol | Pindolol Pindolol may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Cisplatin Injection | Cisplatin Injection Cilostazol may decrease the excretion rate of Cisplatin which could result in a higher serum level. |
Diflunisal | Diflunisal The risk or severity of bleeding can be increased when Diflunisal is combined with Cilostazol. |
Piroxicam | Piroxicam The risk or severity of bleeding can be increased when Piroxicam is combined with Cilostazol. |
Bumetanide | Bumetanide Bumetanide may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy. |
Streptozocin | Streptozocin The metabolism of Cilostazol can be increased when combined with Streptozocin. |
Etoposide | Etoposide The metabolism of Cilostazol can be decreased when combined with Etoposide. |
Glyburide | Glyburide The metabolism of Cilostazol can be decreased when combined with Glyburide. |
Glipizide | Glipizide Glipizide may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Indapamide | Indapamide Indapamide may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy. |
Amoxicillin | Amoxicillin Amoxicillin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Nafcillin Injection | Nafcillin Injection The metabolism of Cilostazol can be increased when combined with Nafcillin. |
Oxacillin Injection | Oxacillin Injection Oxacillin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Pentoxifylline | Pentoxifylline Pentoxifylline may increase the antiplatelet activities of Cilostazol. |
Pentamidine Injection | Pentamidine Injection The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Pentamidine. |
Ceftriaxone Injection | Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Labetalol | Labetalol The metabolism of Cilostazol can be decreased when combined with Labetalol. |
Auranofin | Auranofin Auranofin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Leuprolide Injection | Leuprolide Injection The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Leuprolide. |
Gemfibrozil | Gemfibrozil The serum concentration of Cilostazol can be increased when it is combined with Gemfibrozil. |
Guanabenz | Guanabenz The metabolism of Cilostazol can be decreased when combined with Guanabenz. |
Dipivefrin Ophthalmic | Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Ceftazidime Injection | Ceftazidime Injection Ceftazidime may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Ketoprofen | Ketoprofen The risk or severity of bleeding can be increased when Ketoprofen is combined with Cilostazol. |
Cefotetan Injection | Cefotetan Injection Cefotetan may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Pimozide | Pimozide The metabolism of Cilostazol can be decreased when combined with Pimozide. |
Flurbiprofen | Flurbiprofen The risk or severity of bleeding can be increased when Flurbiprofen is combined with Cilostazol. |
Amiodarone | Amiodarone The metabolism of Cilostazol can be decreased when combined with Amiodarone. |
Aztreonam Injection | Aztreonam Injection Aztreonam may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Buspirone | Buspirone Buspirone may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Lovastatin | Lovastatin The metabolism of Cilostazol can be decreased when combined with Lovastatin. |
Ciprofloxacin | Ciprofloxacin The metabolism of Cilostazol can be decreased when combined with Ciprofloxacin. |
Mesalamine | Mesalamine The risk or severity of bleeding can be increased when Mesalazine is combined with Cilostazol. |
Diclofenac | Diclofenac The risk or severity of bleeding can be increased when Diclofenac is combined with Cilostazol. |
Fluoxetine | Fluoxetine The serum concentration of Cilostazol can be increased when it is combined with Fluoxetine. |
Nimodipine | Nimodipine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Nimodipine. |
Interferon Alfa-2b Injection | Interferon Alfa-2b Injection The metabolism of Cilostazol can be decreased when combined with Interferon alfa-2b. |
Clozapine | Clozapine The serum concentration of Cilostazol can be increased when it is combined with Clozapine. |
Estazolam | Estazolam Cilostazol may decrease the excretion rate of Estazolam which could result in a higher serum level. |
Idarubicin | Idarubicin The risk or severity of bleeding can be increased when Cilostazol is combined with Idarubicin. |
Ofloxacin | Ofloxacin The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Ofloxacin. |
Didanosine | Didanosine Didanosine may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Fludarabine Injection | Fludarabine Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Fludarabine. |
Pentostatin Injection | Pentostatin Injection Pentostatin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Clarithromycin | Clarithromycin The metabolism of Cilostazol can be decreased when combined with Clarithromycin. |
Etodolac | Etodolac The risk or severity of bleeding can be increased when Etodolac is combined with Cilostazol. |
Felodipine | Felodipine The metabolism of Cilostazol can be decreased when combined with Felodipine. |
Fosinopril | Fosinopril Fosinopril may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Nabumetone | Nabumetone The risk or severity of bleeding can be increased when Nabumetone is combined with Cilostazol. |
Simvastatin | Simvastatin The metabolism of Cilostazol can be decreased when combined with Simvastatin. |
Teniposide Injection | Teniposide Injection The metabolism of Cilostazol can be decreased when combined with Teniposide. |
Itraconazole | Itraconazole The metabolism of Cilostazol can be decreased when combined with Itraconazole. |
Lisinopril | Lisinopril Lisinopril may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Oxaprozin | Oxaprozin The risk or severity of bleeding can be increased when Oxaprozin is combined with Cilostazol. |
Sotalol | Sotalol The metabolism of Sotalol can be decreased when combined with Cilostazol. |
Bisoprolol | Bisoprolol Bisoprolol may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Zolpidem | Zolpidem The metabolism of Cilostazol can be decreased when combined with Zolpidem. |
Doxazosin | Doxazosin The metabolism of Cilostazol can be decreased when combined with Doxazosin. |
Isradipine | Isradipine The metabolism of Cilostazol can be decreased when combined with Isradipine. |
Omeprazole | Omeprazole The serum concentration of Cilostazol can be increased when it is combined with Omeprazole. |
Cisapride | Cisapride The metabolism of Cilostazol can be decreased when combined with Cisapride. |
Fluvastatin | Fluvastatin The serum concentration of Cilostazol can be increased when it is combined with Fluvastatin. |
Venlafaxine | Venlafaxine The metabolism of Cilostazol can be decreased when combined with Venlafaxine. |
Fluvoxamine | Fluvoxamine The serum concentration of Cilostazol can be increased when it is combined with Fluvoxamine. |
Nefazodone | Nefazodone The metabolism of Cilostazol can be decreased when combined with Nefazodone. |
Lamotrigine | Lamotrigine The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Cilostazol. |
Losartan | Losartan The serum concentration of Cilostazol can be increased when it is combined with Losartan. |
Valacyclovir | Valacyclovir Valaciclovir may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Tramadol | Tramadol Tramadol may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Vinorelbine Injection | Vinorelbine Injection The metabolism of Cilostazol can be decreased when combined with Vinorelbine. |
Carboplatin Injection | Carboplatin Injection Carboplatin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Moexipril | Moexipril The risk or severity of QTc prolongation can be increased when Moexipril is combined with Cilostazol. |
Lansoprazole | Lansoprazole The serum concentration of Cilostazol can be increased when it is combined with Lansoprazole. |
Ifosfamide Injection | Ifosfamide Injection The metabolism of Cilostazol can be decreased when combined with Ifosfamide. |
Nicardipine | Nicardipine The serum concentration of Cilostazol can be increased when it is combined with Nicardipine. |
Bupropion | Bupropion The metabolism of Cilostazol can be decreased when combined with Bupropion. |
Ticlopidine | Ticlopidine The serum concentration of Cilostazol can be increased when it is combined with Ticlopidine. |
Saquinavir | Saquinavir The metabolism of Cilostazol can be decreased when combined with Saquinavir. |
Metformin | Metformin Metformin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Dalteparin Injection | Dalteparin Injection The risk or severity of bleeding can be increased when Cilostazol is combined with Dalteparin. |
Nisoldipine | Nisoldipine Nisoldipine may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Lamivudine | Lamivudine Lamivudine may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Riluzole | Riluzole The metabolism of Cilostazol can be decreased when combined with Riluzole. |
Acarbose | Acarbose Acarbose may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Gemcitabine Injection | Gemcitabine Injection Gemcitabine may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Indinavir | Indinavir The metabolism of Cilostazol can be decreased when combined with Indinavir. |
Ritonavir | Ritonavir The serum concentration of Cilostazol can be increased when it is combined with Ritonavir. |
Docetaxel Injection | Docetaxel Injection The metabolism of Cilostazol can be decreased when combined with Docetaxel. |
Cidofovir Injection | Cidofovir Injection Cidofovir may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Meropenem Injection | Meropenem Injection Meropenem may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Clomipramine | Clomipramine The serum concentration of Cilostazol can be increased when it is combined with Clomipramine. |
Zafirlukast | Zafirlukast The serum concentration of Cilostazol can be increased when it is combined with Zafirlukast. |
Fosfomycin | Fosfomycin Fosfomycin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Mirtazapine | Mirtazapine The metabolism of Cilostazol can be decreased when combined with Mirtazapine. |
Topiramate | Topiramate The serum concentration of Cilostazol can be increased when it is combined with Topiramate. |
Zileuton | Zileuton The metabolism of Cilostazol can be decreased when combined with Zileuton. |
Insulin Lispro Injection | Insulin Lispro Injection The metabolism of Cilostazol can be increased when combined with Insulin lispro. |
Pramipexole | Pramipexole Pramipexole may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Donepezil | Donepezil The metabolism of Cilostazol can be decreased when combined with Donepezil. |
Nelfinavir | Nelfinavir The metabolism of Cilostazol can be decreased when combined with Nelfinavir. |
Azithromycin | Azithromycin The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Azithromycin. |
Carvedilol | Carvedilol The metabolism of Cilostazol can be decreased when combined with Carvedilol. |
Nilutamide | Nilutamide The serum concentration of Cilostazol can be increased when it is combined with Nilutamide. |
Flutamide | Flutamide The metabolism of Cilostazol can be decreased when combined with Flutamide. |
Selegiline | Selegiline The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Cilostazol. |
Bicalutamide | Bicalutamide The serum concentration of Cilostazol can be increased when it is combined with Bicalutamide. |
Sertraline | Sertraline The serum concentration of Cilostazol can be increased when it is combined with Sertraline. |
Propafenone | Propafenone The metabolism of Cilostazol can be decreased when combined with Propafenone. |
Letrozole | Letrozole The serum concentration of Cilostazol can be increased when it is combined with Letrozole. |
Raloxifene | Raloxifene The metabolism of Cilostazol can be decreased when combined with Raloxifene. |
Irbesartan | Irbesartan The metabolism of Cilostazol can be decreased when combined with Irbesartan. |
Tamsulosin | Tamsulosin Tamsulosin may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Finasteride | Finasteride The metabolism of Finasteride can be decreased when combined with Cilostazol. |
Quetiapine | Quetiapine The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Quetiapine. |
Cefepime Injection | Cefepime Injection Cefepime may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Cefprozil | Cefprozil Cefprozil may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Cefpodoxime | Cefpodoxime Cefpodoxime may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Cetirizine | Cetirizine The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Cilostazol. |
Paroxetine | Paroxetine The serum concentration of Cilostazol can be increased when it is combined with Paroxetine. |
Tolcapone | Tolcapone Tolcapone may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Citalopram | Citalopram The serum concentration of Cilostazol can be increased when it is combined with Citalopram. |
Capecitabine | Capecitabine Capecitabine may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Efavirenz | Efavirenz The serum concentration of Cilostazol can be increased when it is combined with Efavirenz. |
Abacavir | Abacavir Abacavir may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Sildenafil | Sildenafil The serum concentration of Cilostazol can be increased when it is combined with Sildenafil. |
Celecoxib | Celecoxib The metabolism of Cilostazol can be decreased when combined with Celecoxib. |
Rosiglitazone | Rosiglitazone The metabolism of Cilostazol can be decreased when combined with Rosiglitazone. |
Tolterodine | Tolterodine The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Cilostazol. |
Thalidomide | Thalidomide The serum concentration of Cilostazol can be increased when it is combined with Thalidomide. |
Oseltamivir | Oseltamivir Oseltamivir may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Balsalazide | Balsalazide The risk or severity of bleeding can be increased when Balsalazide is combined with Cilostazol. |
Nateglinide | Nateglinide Nateglinide may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Galantamine | Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Cilostazol. |
Rabeprazole | Rabeprazole The serum concentration of Cilostazol can be increased when it is combined with Rabeprazole. |
Terbinafine | Terbinafine The metabolism of Cilostazol can be decreased when combined with Terbinafine. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists